Head and neck cancer in patients with human immunodeficiency virus-1 infection: Incidence, outcome and association with Epstein-Barr virus

Journal of Laryngology and Otology

Volumn 118, Issue 3, 2004, Pages 207-212

  Powles, T ^a   Powles, J ^b   Nelson, M ^a   Sandison, A ^b   Peston, D ^b   Buchannan, J ^a   Mandalia, S ^a   Gazzard, B ^a   Bower, M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral agents; Epstein Barr virus; Head and Neck Cancer; HIV 1; Treatment Outcome

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HEAD AND NECK CANCER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; MALE; NONHUMAN; PATHOGENESIS; SURVIVAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; EPSTEIN-BARR VIRUS INFECTIONS; HEAD AND NECK NEOPLASMS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1842454331     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/002221504322927982     Document Type: Article

References (28)

1. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. J Am Med Assoc 2001;285:1736-45
2. Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000;53:248-54
3. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31
4. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. Aids 1999;13:839-43
5. Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000;14:553-9
6. Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, et al. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001;94:753-7
7. Grulich A, Li Y, McDonald A, Correll P, Law M, Kaldor J. Rates of non-AIDS defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-61
8. Roland JT, Jr., Rothstein SG, Mittal KR, Perksy MS. Squamous cell carcinoma in HIV-positive patients under age 45. Laryngoscope 1993;103:509-11
9. Singh B, Balwally AN, Shaha AR, Rosenfeld RM, Har-El G, Lucente FE. Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Arch Otolaryngol Head Neck Surg 1996;122:639-43
10. Kao GD, Devine P, Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy. Arch Otolaryngol Head Neck Surg 1999;125:873-6
11. Singh B, Sabin S, Rofim, O, Shaha A, Har-El G, Lucente FE. Alterations in head and neck cancer occurring in HIV-infected patients - results of a pilot, longitudinal, prospective study. Acta Oncol 1999;38:1047-50
12. Head and neck. In: Beahrs O, Henson D, Hutter R, Kennedy B, eds. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th edn. Philadelphia, Pa: Lippincott-Raven Publishers, 1997;127-37
13. Therasse P, Arbuck S, Eisenhauer E, Wanders J, Kaplan R, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumours (RECIST guidelines). J Natl Cancer Inst 2000;92:205-16
14. Thames Cancer Registry for SE England, 1st Floor, Capital House, Weston Street, London SE1 3QD; 1996
15. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001;13:183-8
16. Almadori G, Galli J, Cadoni G, Bussu F, Maurizi M. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head Neck 2002;24:597-604
17. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40
18. Izumi KM, Kaye KM, Kieff ED. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA 1997;94:1447-52
19. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001;37:1209-16
20. Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 2001;82:149-70
21. Sand LP, Jalouli J, Larsson PA, Hirsch JM. Prevalence of Epstein-Barr virus in oral squamous cell carcinoma, oral lichen planus, and normal oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:586-92
22. Adler-Storthz K, Ficarra G, Woods KV, Gaglioti D, DiPietro M, Shillitoe EJ. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients. J Oral Pathol Med 1992;21:164-70
23. Gonzalez-Moles MA, Gutierrez J, Rodriguez MJ, Ruiz-Avila I, Rodriguez-Archilla A. Epstein-Barr virus latent membrane protein-1 (LMP-1)_expression in oral squamous cell carcinoma. Laryngoscope 2002;112:482-7
24. Thompson SC, Nanni C, Levin A. The stressors and stress of being HIV-positive. AIDS Care 1996;8:5-14
25. Bundgaard T, Bentzen SM, Wildt J, Sorensen FB, Sogaard H, Nielsen JE. Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity. Head Neck 1996;18:142-52
26. Preciado DA, Matas A, Adams GL. Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 2002;24:319-25
27. Powles T, Imami N, Nelson M, Gazzard BG, Bower M. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002;16:531-6
28. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, et al. Constraints on CD4 recovery post-chemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997;90:3789-98